How is Kt/V (dialysis adequacy) calculated for a hemodialysis session?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Calculate Kt/V for Hemodialysis

For standard thrice-weekly hemodialysis, use the single-pool Kt/V (spKt/V) formula that accounts for the BUN ratio, treatment time, and ultrafiltration volume. 1

Primary Calculation Method: The Daugirdas Formula

The most widely used equation for calculating spKt/V is:

spKt/V = -ln(R - 0.008 × T) + (4 - 3.5 × R) × (UF/W)

Where:

  • R = ratio of postdialysis BUN to predialysis BUN
  • T = treatment time in hours
  • UF = ultrafiltration volume (weight loss) in kg
  • W = postdialysis weight in kg
  • ln = natural logarithm

2

Updated Formula for Non-Standard Dialysis Schedules

For dialysis frequencies other than three times per week (twice weekly, daily, or more frequent schedules), the 2015 KDOQI guideline introduced an important modification:

spKt/V = -ln(R - GFAC × T) + (4 - 3.5 × R) + (3 × 0.55 × Weight loss)/V

The key difference is replacing the constant 0.008 with GFAC (G factor), which ranges from 0.0045 to 0.0175 depending on the preceding interdialysis interval (PIDI). GFAC can be roughly estimated as 0.175 divided by the PIDI in days. 1

Simplified Conceptual Understanding

In the simplest scenario without ultrafiltration or urea generation:

Kt/V = ln(C₀/C)

Where C₀ is predialysis concentration and C is postdialysis concentration. This represents the fractional removal rate of urea from the patient's body water volume. 2

Alternative Simpler Method: Urea Reduction Ratio (URR)

URR = (Predialysis BUN - Postdialysis BUN) / Predialysis BUN

While URR correlates with Kt/V in population studies, it has significant limitations:

  • Does not account for ultrafiltration volume changes
  • Cannot incorporate residual kidney function
  • Less useful for adjusting prescriptions
  • Becomes zero with daily or continuous dialysis

2

Critical Sampling Considerations

Common pitfall: Postdialysis blood samples must be drawn correctly to avoid recirculation errors. The BUN rebounds after dialysis due to multi-compartment urea distribution, so timing and technique of blood sampling significantly affect accuracy. 2

Adding Residual Kidney Function

When patients have residual kidney function (Kru ≥ 2 mL/min), this should be incorporated into the total clearance calculation. However, only add residual kidney clearance if measured within 3 months prior to avoid underdialysis from overestimating native kidney contribution. 1

Modern Alternative: Conductivity-Based Measurement

Online clearance monitors (OCM) using ionic dialysance can calculate Kt/V in real-time without requiring postdialysis blood sampling. This method uses conductivity clearance (Kecn) and a calibrated patient-specific volume (Vcal). Studies show good concordance with traditional URR-based methods, with the advantage of avoiding blood sampling errors. 3, 4, 5

Practical Application

For routine clinical practice with thrice-weekly hemodialysis:

  1. Obtain predialysis and postdialysis BUN values
  2. Record treatment time in hours
  3. Measure ultrafiltration volume (pre-weight minus post-weight)
  4. Apply the Daugirdas formula above
  5. Target minimum spKt/V ≥ 1.2-1.4 per session

For non-standard schedules (twice weekly, daily, or more frequent), use the updated formula with GFAC adjustment to account for differences in interdialytic urea generation. 1

The choice of calculation method should consider dialysis frequency, availability of technology (OCM vs laboratory BUN), and presence of residual kidney function, as these factors significantly impact the accuracy of different formulas.

References

Guideline

kdoqi clinical practice guideline for hemodialysis adequacy: 2015 update.

American Journal of Kidney Diseases, 2015

Guideline

clinical practice guidelines for hemodialysis adequacy, update 2006.

American Journal of Kidney Diseases, 2006

Research

Quantification of hemodialysis dose: what Kt/V 
to choose?

The International journal of artificial organs, 2014

Related Questions

What is the dialysis adequacy index Kt/V (clearance × time ÷ volume) and what are the recommended target values for hemodialysis?
What is Kt/V in hemodialysis?
How should a 6 mm non‑obstructing kidney stone be managed?
In a 61‑year‑old male with end‑stage renal disease (chronic kidney disease stage 5) on thrice‑weekly hemodialysis via a right internal‑jugular dialysis catheter who developed chills and a single episode of vomiting during a dialysis session, has leukocytosis, bilateral pleural effusions, new‑onset pneumonia, markedly elevated transaminases, severe hypokalemia, hypomagnesemia, hypophosphatemia, and combined respiratory alkalosis with metabolic acidosis, what is the appropriate empiric antimicrobial regimen and catheter management for a suspected catheter‑related bloodstream infection?
In a 27-year-old male with known aplastic anemia presenting with abdominal pain, weakness, pallor, pancytopenia, and acute kidney injury unresponsive to antibiotics and dialysis, with normal renal ultrasound, elevated creatinine, metabolic acidosis, elevated AST, indirect hyperbilirubinemia, high LDH, elevated D‑dimer, negative direct and indirect Coombs, and normal PT/aPTT, how should a complete diagnosis and management plan be formulated according to Harrison and Philippine guidelines, including chart ordering, identification of missing diagnostics, and documentation in SOAP format?
What is the recommended management for dystonia?
What medications are used to induce ovulation?
What is the recommended management for a patient with frequent headaches (≥2–3 days per week or >15 days per month)?
In a 70‑kg adult with normal renal function, what are the clinical indications, recommended dose, contraindications, monitoring parameters, and alternative options for L‑arginine supplementation?
When should clomiphene citrate (Clomid) be started in a reproductive‑age woman with documented anovulatory infertility and a normal fertility work‑up?
What are the anesthetic considerations for a 40-year-old female patient diagnosed with hyperthyroidism 10 days ago who will undergo emergency orbital decompression surgery for optic nerve damage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.